1. Home
  2. MDV vs MOLN Comparison

MDV vs MOLN Comparison

Compare MDV & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Modiv Industrial Inc. Class C

MDV

Modiv Industrial Inc. Class C

HOLD

Current Price

$14.45

Market Cap

149.6M

ML Signal

HOLD

Logo Molecular Partners AG

MOLN

Molecular Partners AG

HOLD

Current Price

$4.34

Market Cap

164.2M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDV
MOLN
Founded
2015
2004
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Transportation Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
149.6M
164.2M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
MDV
MOLN
Price
$14.45
$4.34
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
$3.75
AVG Volume (30 Days)
35.1K
4.1K
Earning Date
11-14-2025
02-11-2026
Dividend Yield
8.10%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$47,479,000.00
N/A
Revenue This Year
$0.13
N/A
Revenue Next Year
$0.71
$999.99
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.62
$3.36
52 Week High
$17.15
$5.91

Technical Indicators

Market Signals
Indicator
MDV
MOLN
Relative Strength Index (RSI) 44.84 52.50
Support Level $14.23 $4.20
Resistance Level $14.81 $4.60
Average True Range (ATR) 0.31 0.17
MACD -0.04 -0.00
Stochastic Oscillator 25.28 61.76

Price Performance

Historical Comparison
MDV
MOLN

About MDV Modiv Industrial Inc. Class C

Modiv Industrial Inc is a pioneer in the direct-to-consumer commercial real estate product industry. It provides individual investors access to real estate and real estate-related investments designed to provide both income and long-term growth. The Company has invested in single-tenant income-producing properties. Its current business consists of owning, managing, operating, leasing, acquiring, investing in and disposing of commercial real estate assets utilized for industrial manufacturing, as well as a few non-core assets. All of the company's consolidated revenues are derived from company's consolidated real estate properties.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

Share on Social Networks: